Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 402 (2021-2022)

https://ontology.bommaritollc.com/id/01a0d568-48b2-7531-a3cc-94684996f62b

adms:identifier	mi-legislature-measure 2021-2022/SB/402
dcterms:temporal	Michigan Legislature, 2021-2022 session
primary sponsor	Edward W McBroom
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-SB-0402 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-SB-0402 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-SB-0402
schema:legislationChanges	MCL 333.17766f
schema:legislationIdentifier	SB 402
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; allowable amount of ephedrine and pseudoephedrine that may be sold at retail to an individual in a 30-day period; modify. Amends sec. 17766f of 1978 PA 368 (MCL 333.17766f ). TIE BAR WITH: SB 0401'21en
schema:sponsor	Edward W McBroom
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2021-SB-0402
skos:prefLabel	SB 402 (2021-2022)en
status	in committee
status date	2021-05-25xsd:date